Cell and gene therapies are relatively new to the biopharmaceutical space, and the development of efficient, reliable manufacturing processes for these advanced therapy medicinal products (ATMPs) can be challenging to navigate without the right partner. It is critical to work with an experienced, dependable, and collaborative CDMO that not only has the necessary technical and manufacturing capacities to support the development and production of cell and gene therapies, but also the expertise to tackle any challenge that may arise.
Rentschler ATMP provides a highly experienced team, well-versed in viral vector process development and cGMP manufacturing. We deliver a tailored and collaborative boutique-like experience to support our clients in getting their products to clinic. We have the experience, technology, analytical expertise, and development and manufacturing capabilities to support the unique needs of advanced therapies.